Figgs: I agree that $10-12 would represent a fair
Post# of 148190
FDA documented hostility to Leronlimab approval vs Leronlimab's
documented potential to become the world's top revenue drug within 3-4
years of FDA approval.
What may be very difficult for new CYDY management to accomplish with the FDA may be considerably easier to accomplish for any well connected BP.